1st Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions

The 1st Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions was a meeting held by the World Health Organization (WHO) on March 29, 2021.1)

The event was followed by the 2nd Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions on June 10, 2021.2)

Participants

Name Affiliation Topic
Michael Ryan World Health Organization Opening remarks
Sylvie Briand World Health Organization WHO framework for monitoring & assessing SARS-CoV-2 variants
Session 1: Focus on SARS-CoV-2 Variants
Maria Van Kerkhovea World Health Organization Moderator
Boris Pavlin World Health Organization Epi update on SARS-CoV-2 variants of concern
Frank Konings World Health Organization Status of assessment of mutations, VOI and VOC in terms of understanding transmissibility, severity and potential impact on countermeasures
Volker Thiel University of Bern How WHO assesses knowledge and knowledge gaps and develops advice and guidance
Janet Diaz World Health Organization -
April Baller World Health Organization -
Session 2: Framework of Evidence for the SARS-CoV-2 Variants
Wenqing Zhang World Health Organization Moderator
John McCauley Francis Crick Institute Experience from influenza: vaccine virus selection system and risk assessment framework
Richard Webby St. Jude Children's Research Hospital Experience from influenza: vaccine virus selection system and risk assessment framework
Ana Maria Henao Restrepo R&D Blueprint, World Health Organization Moderator
Philip Krause Food and Drug Administration (FDA) Building a framework of evidence for the monitoring and assessment of vaccines in the context of SARS-CoV-2 variants
Kanta Subbarao Peter Doherty Institute for Infection and Immunity Moderator
Jakob Cramer Coalition for Epidemic Preparedness Innovations (CEPI) Structured Debate introduced by Ana Maria Henao Restrepo
Paul Fine London School of Hygiene and Tropical Medicine Structured Debate introduced by Ana Maria Henao Restrepo
Thomas Fleming University of Washington Structured Debate introduced by Ana Maria Henao Restrepo
Alan Khoo International Medical University Structured Debate introduced by Ana Maria Henao Restrepo
Ira Longini University of Florida Structured Debate introduced by Ana Maria Henao Restrepo
Cesar Muñoz-Fontela R&D Blueprint, World Health Organization Structured Debate introduced by Ana Maria Henao Restrepo
Richard Neher University of Basel Structured Debate introduced by Ana Maria Henao Restrepo
Jerome Singh University of KwaZulu-Natal Structured Debate introduced by Ana Maria Henao Restrepo
David Wentworth Centers for Disease Control and Prevention (CDC) Structured Debate introduced by Ana Maria Henao Restrepo
Session 3: Impact on Public Health Decision-Making
Katherine O'Brien World Health Organization Moderator
Soumya Swaminathan World Health Organization Interplay between vaccine supply, vaccine performance, and emergence of SARS-CoV-2 variants
Sarah Cobey University of Chicago Interplay between vaccine supply, vaccine performance, and emergence of SARS-CoV-2 variants
Annelies Wilder-Smith World Health Organization Interplay between vaccine supply, vaccine performance, and emergence of SARS-CoV-2 variants
Rogerio Gaspar World Health Organization Moderator
Philip Krause Food and Drug Administration (FDA) Perspectives from regulators and developers
Adam Hacker Coalition for Epidemic Preparedness Innovations (CEPI) Perspectives from regulators and developers
Boitumelo Semete South Africa Health Products Regulatory Authority Perspectives from regulators and developers
V.G. Somani Central Drugs Standard Control Organization Perspectives from regulators and developers
David Heymann WHO Strategic and Technical Advisory Group for Infectious Hazards Impact on public health decision-making
Alejandro Cravioto WHO Strategic Advisory Group of Experts on Immunization (SAGE) Impact on public health decision-making

Contributors

1)
Global Consultation on a Decision Framework for Assessing the Impact of SARS-CoV-2 Variants of Concern on Public Health Interventions. (2021, March 29). World Health Organization. https://web.archive.org/web/20230311214713/https://www.who.int/publications/m/item/global-consultation-on-a-decision-framework-for-assessing-the-impact-of-sars-cov-2-variants-of-concern-on-public-health-interventions
2)
2nd Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions. (2021). World Health Organization. https://web.archive.org/web/20230312032446/https://www.who.int/docs/default-source/coronaviruse/report-sars-global-consultation_10june2021.pdf
Back to top